Trial intelligence / Profile preview

Pentoxifylline for prevention of periprocedural cardiac injury after angioplasty

IRCT201402068307N4Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pentoxifylline in coronary arteriosclerosis, sponsored by Tabriz University of Medical Sciences. Started Dec 2013; status: completed.

02

Drugs

pentoxifylline
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on IRCT201402068307N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201402068307N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call